Establishment and characterization of a human cell line from paediatric cerebellar glioblastoma multiforme

Neuropathology and Applied Neurobiology

Volumn 26, Issue 1, 2000, Pages 22-30

  Di Tomaso, E ^a,b   Pang, J C S ^a   Ng, H K ^a   Lam, P Y P ^a   Tian, X X ^a   Suen, K W ^a   Hui, A B Y ^a   Hjelm, N M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell line; EGFR; Glioblastoma; Karyotype; p16(CDKN2A); p53; PTEN; Telomerase

Indexed keywords

AGAR; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P53; TELOMERASE; VIMENTIN;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CASE REPORT; CELL CULTURE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CEREBELLUM TUMOR; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 5; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADOLESCENT; CARCINOGENICITY TESTS; CELL CULTURE TECHNIQUES; CELL DIVISION; CEREBELLAR NEOPLASMS; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; KARYOTYPING; PHOSPHORIC MONOESTER HYDROLASES; POINT MUTATION; PROTO-ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOBLASTOMA PROTEIN; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0034062429     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2000.00214.x     Document Type: Article

References (35)

1. 1 Bacciocchi G, Gibelli N, Zibera C et al. Establishment and characterization of two cell lines derived from human glioblastoma multiforme. Anticancer Res 1992; 12: 853-61
2. 2 Bakir A, Gezen F, Yildiz O et al. Establishment and characterization of a human glioblastoma multiforme cell line. Cancer Genet Cytogenet 1998; 103: 46-51
3. 3 Bigner DD, Bigner SH, Ponten J et al. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 1981; 40: 201-29
4. 4 Bhattacharjee MB, Armstrong DD, Vogel H, Cooley LD. Cytogenetic analysis of 120 primary paediatric brain tumors and literature review. Cancer Genet Cytogenet 1997; 97: 9-53
5. 5 Brat DJ, James D, Jedlicka AE et al. Molecular genetic alterations in radiation-induced astrocytomas. Am J Pathol 1999; 154: 1431-8
6. 6 Chiariella E, Roz L, Albarosa R, Magnani I, Finocchiaro G. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene 1998; 16: 541-5
7. 7 Chauzy C, Delpech B, Olivier A et al. Establishment and characterisation of a human glioma cell line. Eur J Cancer 1992; 28: 1129-34
8. 8 Cheney IW, Johnson DE, Vaillancourt M-T el al. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 1998; 58: 2331-4
9. 9 Cheng Y, Ng HK, Ding M, Zhang S, Pang JCS, Lo KW. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. J Neuropathol Exp Neurol 1999; 58: 120-8
10. 10 Chong EYY, Lam PYP, Poon WS, Ng HK. Telomerase expression in gliomas including the nonastrocytic tumors. Human Pathol 1997; 29: 599-603
11. 11 Dahl D, Ruegger DC, Bignami A. Vimentin, the 57000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur J Cell Biol 1981; 24: 191-6
12. 12 Dohrmann GJ, Farwell JR, Flannery JT. Glioblastoma multiforme in children. J Neurosurg 1976; 44: 442-8
13. 13 Duffy PE, Huang YY, Rapport MM. The relationship of GFAP to the shape, motility, and differentiation of human astrocytoma cells. Exp Cell Res 1982; 139: 145-57
14. 14 Furnari FB, Lin H, Huang H-JS, Cavenee WK. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997; 94: 12479-84
15. 15 Henn W, Blin N, Zang KD. Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines. Hum Genet 1986; 74: 104-6
16. 16 Hiraga S, Ohnishi T, Izumoto S et al. Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 1998; 58:2117-25
17. 17 Karlbom AE, James CD, Boethius J et al. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 1993; 92: 169-74
18. 18 Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5
19. 19 Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-7
20. 20 Litofsky NS, Hinton D, Raffel C. The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurery 1994; 34: 967-72
21. 21 Maunoury R. Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol 1977; 39: 33-41
22. 22 Nagane M, Coufal F, Lin H et al. A common mutated epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 1996; 56: 5079-86
23. 23 Ng HK, Lam PYP. The molecular genetics of central nervous system tumors. Pathology 1998; 30: 196-202
24. 24 Pollack IF, Hamilton RL, Finkelstein SD et al. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 1997; 57: 304-9
25. 25 Pomeroy SL. The p53 tumor suppressor gene and pediatric brain tumors. Curr Opin Pediatr 1994; 6: 632-5
26. 26 Spector DL, Goldman ED, Leinwand LA, Eds. Growth and manipulation of cells in culture. In Cells, A Laboratory Manual Vol 1: Culture and Biochemical Analysis of Cells. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1998: 2.14-2.16.
27. 27 Steck PA, Pershouse MA. Tasser SA et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356-62
28. 28 Sure U, Ruedi D, Tachibana O et al. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. Neuropathol Exp Neurol 1997; 56: 782-9
29. 29 Tamura M, Gu J, Matsumoto K et al. Inhibition of cell migration, spreading, and Focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-7
30. 30 Tang P, Steck PA, Yung WKA. The autocrine loop of TGF-αEGFR and brain tumors. J Neuro-Oncol 1997; 35: 303-14
31. 31 Tong CYK, Ng HK, Pang JCS, Hui ABY, Ko HCW, Lee JCK. Molecular genetic analysis of non-astrocytic gliomas. Histopathol 1999; 34: 331-41
32. 32 Tian XX, Lam PYP, Chen J, Pang JCS, To SST, Di-Tomaso E, Ng HK. Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation. Neuropathol App Neurobiol 1998; 24: 389-96
33. 33 Ueki K, Ono Y, Henson JW et al. CDKN2/p16 or Rb alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996; 56: 150-3
34. 34 Westphal M, Hansel M, Hamel W et al. Karyotype analyses of 20 human glioma cell lines. Acta Neurochir 1994; 126: 17-26
35. 35 Wong AJ, Bigner SH, Bigner DD et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl Acad Sci USA 1992; 84: 6899-903